Physician
Irfani, Samia
Irfani, Samia was paid $1.34M by Medicaid between Feb 2018 and Nov 2024, across 45 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.
33Billing provider infoIRFANI, SAMIA
CHICAGO, IL 60612
CHICAGO, IL 60612
33aNPI1437326907assigned 05/13/2008
33bProvider typePediatrics Physician
28Total paid$1.34M
24GClaims36,504
24DCodes billed45
24AFirst – last monthFeb 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Illinois
Rank by total paid#95 of 1,805
Median peer was paid$55K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,746 | $121K | |
| 2019 | 5,419 | $176K | |
| 2020 | 5,814 | $188K | |
| 2021 | 5,954 | $235K | |
| 2022 | 7,002 | $268K | |
| 2023 | 4,928 | $179K | |
| 2024incomplete | 3,641 | $168K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 42% | 11,532 | 9,818 | $558K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 11% | 1,785 | 1,502 | $151K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 9.3% | 1,636 | 1,371 | $125K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.2% | 1,401 | 1,207 | $109K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 3.9% | 1,208 | 1,153 | $52K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.7% | 1,434 | 1,336 | $49K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.3% | 1,720 | 1,621 | $44K |
| 92587 | 3.0% | 3,088 | 2,512 | $40K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.9% | 509 | 399 | $39K |
| 92015 | Determination of refractive state | 2.8% | 2,082 | 1,855 | $37K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.5% | 1,379 | 1,267 | $20K |
| 90651 | <1% | 636 | 507 | $13K |
33 more codes
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 729 | $12K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,614 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 204 | $10K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 133 | $9K |
| 90686 | <1% | 790 | $8K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 385 | $8K |
| 90734 | <1% | 538 | $8K | |
| 90620 | <1% | 276 | $5K | |
| 0071A | <1% | 84 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 254 | $4K |
| 86580 | <1% | 653 | $3K | |
| 0072A | <1% | 65 | $3K | |
| 0001A | <1% | 56 | $2K | |
| 90621 | <1% | 112 | $2K | |
| 90715 | <1% | 149 | $2K | |
| 90658 | <1% | 217 | $2K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 40 | $1K |
| 90670 | <1% | 87 | $1K | |
| 90744 | <1% | 84 | $661.27 | |
| 90700 | <1% | 47 | $646.07 | |
| 83655 | <1% | 52 | $617.31 | |
| 0003A | <1% | 12 | $518.34 | |
| 90672 | <1% | 67 | $422.40 | |
| 90707 | <1% | 29 | $395.54 | |
| 99422 | <1% | 15 | $379.96 | |
| 90633 | <1% | 28 | $349.20 | |
| 91300 | <1% | 65 | $277.73 | |
| 90713 | <1% | 16 | $271.56 | |
| 90647 | <1% | 15 | $248.18 | |
| 85018 | <1% | 55 | $124.24 | |
| 90716 | <1% | 14 | $76.80 | |
| 91307 | <1% | 92 | $30.22 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 117 | $13.72 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.